Results 11 to 20 of about 226,168 (262)
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023 Background Myocardial revascularization has been advocated to improve myocardial function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for revascularization in patients with ICM and the role of ischemia and viability detection ...
R. Liga +4 more
semanticscholar +1 more source
Rivaroxaban in Peripheral Artery Disease after Revascularization.
New England Journal of Medicine, 2020 BACKGROUND Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain.
Marc P. Bonaca +21 more
semanticscholar +1 more source
Advances in Revascularization for Peripheral Artery Disease
Circulation Research, 2021 Effective revascularization of the patient with peripheral artery disease is about more than the procedure. The approach to the patient with symptom-limiting intermittent claudication or limb-threatening ischemia begins with understanding the population ...
J. Beckman, P. Schneider, M. Conte
semanticscholar +1 more source
Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines
Рациональная фармакотерапия в кардиологии, 2021 Coronary revascularization is one of the most studied types of interventions in cardiology, but there is no consensus among specialists about the indications for its implementation in patients with chronic coronary syndromes (CCS).
L. L. Bershtein +2 more
doaj +1 more source
Children, 2023 Hutchinson–Gilford progeria syndrome is an extremely rare genetic disease caused by a de novo mutation in the LMNA gene, leading to an accumulation of a form of Lamin A, called Progerin, which results in a typical phenotype and a marked decrease in life ...
Luciano De Simone +8 more
doaj +1 more source
Cells, 2023 Clinical islet transplantation is limited by ischemia-induced islet cell death. Recently, it has been reported that the absent in melanoma (AIM)2 inflammasome is upregulated by ischemic cell death due to recognition of aberrant cytoplasmic self-dsDNA ...
Selina Wrublewsky +5 more
doaj +1 more source
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization
Nature Reviews Cardiology, 2021 Patients who have undergone coronary artery bypass graft (CABG) surgery are susceptible to bypass graft failure and progression of native coronary artery disease.
F. Beerkens +7 more
semanticscholar +1 more source
Complete Revascularization with Multivessel PCI for Myocardial Infarction.
New England Journal of Medicine, 2019 BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction.
S. Mehta +31 more
semanticscholar +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundRecent studies have shown improving survival after cardiac arrest. However, data regarding sex‐based disparities in treatment and outcomes after cardiac arrest are limited.
Luke K. Kim +10 more
doaj +1 more source
Heart India, 2022 Although revascularization of a femoropopliteal (CTO) always remains challenging through a retrograde or contralateral crossover approach, we report a case of successful revascularization of a long-segment femoropopliteal CTO through antegrade femoral ...
Debasish Das +4 more
doaj +1 more source